Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-17

Clinical Trial Update: An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports efficacy and safety results of abiraterone acetate with prednisone in men with prostate cancer who progressed after androgen d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Abiraterone acetate)
  • PREDNISONE (Prednisone)

Snippet

Sponsor: Cougar Biotechnology, Inc. | Conditions: Prostatic Neoplasms, Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-06-17